1. TNFR2 promotes Adriamycin resistance in breast cancer cells by repairing DNA damage
   Fuqian Yang et al, 2017, Molecular Medicine Reports CrossRef
2. Adipocytes induce distinct gene expression profiles in mammary tumor cells and enhance inflammatory signaling in invasive breast cancer cells
   Annina Nickel et al, 2018, Scientific Reports CrossRef
3. Extensive variation between tissues in allele specific expression in an outbred mammal
   Amanda J. Chamberlain et al, 2015, BMC Genomics CrossRef
4. TFF1 gene single nucleotide polymorphism (rs3761376) and colorectal cancer risk
   Ramin Shekarriz et al, 2022, Molecular Biology Reports CrossRef
5. Aorta Regulatory T Cells with a Tissue‐Specific Phenotype and Function Promote Tissue Repair through Tff1 in Abdominal Aortic Aneurysms
   Jingyong Li et al, 2022, Advanced Science CrossRef
6. miR218-5p regulates the proliferation of gastric cancer cells by targeting TFF1 in an Erk1/2-dependent manner
   Ying Shi et al, 2015, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
7. A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer
   Courtney D. Dill et al, 2021, iScience CrossRef
8. Evaluating the Utility of Trefoil Factor 1 as a Mammary-Specific Immunostain Compared and in Conjunction With GATA-3 and Mammaglobin in the Distinction Between Carcinoma of Breast and Lung
   Justin M. Wells et al, 2015, American Journal of Clinical Pathology CrossRef
9. miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner
   Ying Shi et al, 2019, BMC Cancer CrossRef
10. Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications
    Rahat Jahan et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
11. E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
    Xinxing Ye et al, 2022, Disease Markers CrossRef
12. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers
    Jie Yi et al, 2020, Biomedicine & Pharmacotherapy CrossRef
13. Potential of Estradiol‐Functionalized Polyisocyanide Hydrogels for Stimulating Tissue Regeneration of the Pelvic Floor
    Melissa J. J. van Velthoven et al, 2024, Advanced Therapeutics CrossRef
14. Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis
    Lili Ren et al, 2021, Bioengineered CrossRef
15. CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3
    Lucas Porras et al, 2022, Cancers CrossRef
16. X-box binding protein 1 (XBP1): a potential role in chemotherapy response, clinical pathologic features, non-inflamed tumour microenvironment for breast cancer
    Zhipeng Zhu et al, 2022, Bioscience Reports CrossRef
17. BQ323636.1, a Novel Splice Variant toNCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer
    Chun Gong et al, 2018, Clinical Cancer Research CrossRef
18. Genome-wide analysis of mRNA expression identified the involvement of trefoil factor 1 in the development of sessile serrated lesions
    Tamotsu Sugai et al, 2022, Pathology - Research and Practice CrossRef
19. MicroRNA‑16 sensitizes drug‑resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl‑2
    Xitao Gao et al, 2019, Oncology Letters CrossRef
20. Unveiling Gene Regulatory Networks That Characterize Difference of Molecular Interplays Between Gastric Cancer Drug Sensitive and Resistance Cell Lines
    Heewon Park, 2024, Journal of Computational Biology CrossRef